A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Name: A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Published: 2013
License: Public Domain

GlaxoSmithKline · 2013

ClinicalTrials.gov · Datasets · License: Public Domain · 2013

Open Source ↗

chronic-obstructive chronic-obstructive-pulmonary-disease lung-function pulmonary-disease

pulmonary disease, chronic obstructive, umeclidinium bromide (umec), vilanterol (vi), salmeterol (sal), fluticasone propionate (fp), novel dry powder inhaler (ndpi), chronic obstructive pulmonary disease, gw642444, gsk573719, lung function, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Related documents